Filing Flows

Filing Flows › Financials › CME Group (CME)

CME Group (CME) earnings and revenue breakdown

Latest: Q3 2026 · 10-Q filed Oct 23, 2026 · CME Group (CME) Q3 2026 earnings results →

Q3 2026 Revenue up 13% year over year to $1.7B · 60¢ of every $1 of revenue kept as net profit · operating margin 65.7%

CME Group made $1.7B in Q3 2026 (+13% Y/Y): Clearing and transaction fees $1.4B, Market data and information services $243M, Other $116M. Operating margin 65.7%, net earnings $1.0B. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Oct 23, 2026.

Revenue$1.7B
Year over year+13%
Operating margin65.7%
Net earnings$1.0B
Operating cash flow$1.1B

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

CME Group Q3 2026 revenue breakdown: Sankey diagram of revenue (Clearing and transaction fees, Market data and information services, Other), costs, profit and cash flow
CME Group Q3 2026 revenue breakdown — free to use with credit and a link (terms). Share on X
Embed this chart on your site

Free to use with the credit line. Click a box to select the code.

What changed this quarter

Revenue was $1.7B in Q3 2026, up 13% year over year and up 2% from the previous quarter. Clearing and transaction fees was the largest line at 79% of revenue. Clearing and transaction fees added $0.15B year over year (up 12%), 75% of the total change.

Operating profit was $1.1B, a 65.7% margin (up 2.4 points year over year). Of the extra revenue versus Q3 2025, 85% reached operating profit, above the 63% margin then. Total costs grew 5% against revenue growth of 13%. Net earnings were $1.0B, up 14% year over year. The effective tax rate was 23.5%.

Operating cash flow was $1.1B (up 12% year over year), 105% of net earnings. Non-cash charges added back $0.08B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items used $0.06B. Capital expenditures of $0.02B left free cash flow of $1.1B.

Quarterly history

CME Group revenue by quarterCME Group revenue by quarter$1.6BQ1 2025$1.7BQ2 2025$1.5BQ3 2025$1.6BQ4 2025$1.9BQ1 2026$1.7BQ2 2026$1.7BQ3 2026
CME Group net earnings by quarterCME Group net earnings by quarter$944MQ1 2025$1.0BQ2 2025$908MQ3 2025$1.2BQ4 2025$1.2BQ1 2026$1.0BQ2 2026$1.0BQ3 2026
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q3 202610-QOct 23, 2026$1.7B+13%65.7%$1.0B$1.1B
Q2 202610-QJul 24, 2026$1.7B+0.8%64.9%$1.0B$947M
Q1 202610-QApr 24, 2026$1.9B+14%69.7%$1.2B$1.3B
Q4 202510-KFeb 26, 2026$1.6B+8%61.8%$1.2B$1.1B
Q3 202510-QOct 24, 2025$1.5B-3%63.3%$908M$968M
Q2 202510-QJul 25, 2025$1.7B+10%66.7%$1.0B$1.1B
Q1 202510-QApr 30, 2025$1.6B+10%67.5%$944M$1.1B

Charts

CME Group: revenue growth, year over year and quarter over quarterCME Group: revenue growth, year over year and quarter over quarterY/YQ/Q+10%Q1 2025+10%+3%Q2 2025-3%-9%Q3 2025+8%+7%Q4 2025+14%+14%Q1 2026+1%-9%Q2 2026+13%+2%Q3 2026
Latest (Q3 2026): Y/Y +13%, Q/Q +2%.
CME Group: where the cash came from (+) and went (−), TTM to Q3 2026CME Group: where the cash came from (+) and went (−), TTM to Q3 2026Cash drawn (+) / kept (−)−$5.9BOperating cash flow$4.4BOther financing$4.1BDividends−$4.1BOther investing$1.6BCapital spending−$93.7MTaxes on employees’ shares−$47.4MNet borrowing (+) / repaid (−)−$17.6M
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
CME Group: profit against cash, quarter by quarterCME Group: profit against cash, quarter by quarterNet incomeOperating cash flow$864M$1.0BQ4 2024$944M$1.1BQ1 2025$1.0B$1.1BQ2 2025$908M$968MQ3 2025$1.2B$1.1BQ4 2025$1.2B$1.3BQ1 2026$1.0B$947MQ2 2026$1.0B$1.1BQ3 2026
Latest (Q3 2026): Net income $1.0B, Operating cash flow $1.1B.
CME Group: diluted shares by fiscal yearCME Group: diluted shares by fiscal year359MFY2020359MFY2021359MFY2022360MFY2023360MFY2024360MFY2025
+0.5% since FY2020: more shares outstanding (issuance, stock pay).
CME Group: long-term debt falling due (FY2025)CME Group: long-term debt falling due (FY2025)$500M2028$750M2030$2.2BLater
Cash $4.4B, short-term investments $125M, long-term debt — at 2025-12-31.
CME Group in its industry: growth against margin (9 companies, SIC 6200)CME Group in its industry: growth against margin (9 companies, SIC 6200)revenue growth, year over year →↑ operating marginmedian +17%median 31%SNEXLPLAICENDAQCBOEBGCTWTOPCME (+13%, 66%)
Security & Commodity Brokers, Dealers, Exchanges & Services; dot size is quarterly revenue; dashed lines are the industry's medians.

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🔄Rotation against the market and its industry (RRG)interactive

Loading the interactive chart…

🔍Earnings qualityinteractive

Loading the interactive chart…

⚖️Fair value by methodinteractive

Loading the interactive chart…

🔭Outlook & guidanceinteractive

Loading the interactive chart…

📈Investments: gains and what it boughtinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

About CME Group

CME Group enables clients to trade futures, options, cash and over-the-counter (OTC) products, optimize portfolios and analyze data - empowering market participants worldwide to efficiently manage risk and capture opportunities. CME Group provides primary price discovery and referential pricing information through its market data in a variety of formats, including real-time, historical and derived data for customers in both listed and cash products. CME Group also offers industry-leading research and analytics tools to provide customers with market education resources. In addition, it operates one of the world's leading central counterparty clearing providers.

In its own words, from its 10-K, filed Feb 26, 2026.

CME Group against its Security & Commodity Brokers, Dealers, Exchanges & Services peers

The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +13% against the peers' median +17%. Operating margin: 65.7% against the peers' median 30.6%.

CompanyQuarterRevenueY/YOp. margin
CME CME GroupQ3 2026$1.7B+13%65.7%
SNEX StoneX GroupQ3 FY26$40.2B+15%0.4%
LPLA LPL Financial HoldingsQ3 2026$5.3B+17%9.1%
ICE Intercontinental ExchangeQ3 2026$3.6B+21%38.8%
NDAQ NasdaqQ3 2026$2.4B+21%30.6%
CBOE Cboe Global MarketsQ3 2026$1.4B+19%39.3%
BGC BGC GroupQ3 2026$833M+13%11.8%
TW Tradeweb MarketsQ3 2026$585M+15%43.4%
TOP TOP Financial GroupQ2 FY27$2.2M+44%12.4%

Source: CME Group 10-Q on SEC EDGAR · CIK 1156375 · Security & Commodity Brokers, Dealers, Exchanges & Services

13F: who owns CME and who is buying

Largest holders of CME (13F)Largest holders of CME (13F)Vanguard Group$9.8BBlackRock$6.7BVanguard Capital Management LLC$5.2BState Street$3.6BMorgan Stanley$2.1BGeode Capital Management, LLC$2.0BVanguard Portfolio Management LLC$2.0BCapital World Investors$1.5BSanders Capital, LLC$1.3BAmeriprise Financial$963M
Funds' net buying of CME by quarter (13F)Funds' net buying of CME by quarter (13F)−$1.6B2024-09−$566M2024-12$489M2025-03$422M2025-06$878K2025-09$91.4M2025-12$922M2026-03$96.1M2026-06
Value of shares 13F filers added minus the value they sold, each quarter (quarters with most filings in).

More on CME

History

Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results

Compare CME with

中文版:芝商所(CME)财报

Español · Français